Mueck A - Search Results

1

EMAS position statement: Testosterone replacement therapy in the aging male‏.

Dimopoulou C, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, Rees M, van der Schouw YT, Senturk LM, Simonsini T, Stevenson JC, Stute P, Goulis DG. Dimopoulou C, et al. Among authors: mueck a. Maturitas. 2016 Feb;84:94-9. doi: 10.1016/j.maturitas.2015.11.003. Epub 2015 Nov 10. Maturitas. 2016. PMID: 26614257 Review.

2

Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.

Mueck AO, Seeger H, Lüdtke R, Gräser T, Wallwiener D. Mueck AO, et al. Maturitas. 2001 May 30;38(3):305-13. doi: 10.1016/s0378-5122(01)00169-4. Maturitas. 2001. PMID: 11358648 Clinical Trial.

3

Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women.

Mueck AO, Seeger H, Wallwiener D. Mueck AO, et al. Maturitas. 2002 Oct 25;43(2):87-93. doi: 10.1016/s0378-5122(02)00160-3. Maturitas. 2002. PMID: 12385856

4

Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women.

Mueck AO, Seeger H. Mueck AO, et al. Maturitas. 2004 Nov 15;49(3):189-203. doi: 10.1016/j.maturitas.2004.01.010. Maturitas. 2004. PMID: 15488347 Review.

5

Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.

Seeger H, Deuringer FU, Wallwiener D, Mueck AO. Seeger H, et al. Maturitas. 2004 Nov 15;49(3):235-40. doi: 10.1016/j.maturitas.2004.02.004. Maturitas. 2004. PMID: 15488352

6

Breast cancer: are oestrogen metabolites carcinogenic?

Mueck AO, Seeger H. Mueck AO, et al. Maturitas. 2007 May 20;57(1):42-6. doi: 10.1016/j.maturitas.2007.02.011. Epub 2007 Mar 26. Maturitas. 2007. PMID: 17383836 Review.

7

In vitro effects of tibolone and its metabolites on human vascular coronary cells.

Seeger H, Kloosterboer HJ, Studen M, Wallwiener D, Mueck AO. Seeger H, et al. Among authors: mueck ao. Maturitas. 2007 Sep 20;58(1):42-9. doi: 10.1016/j.maturitas.2007.04.011. Epub 2007 Jun 15. Maturitas. 2007. PMID: 17572028

8

Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.

Bitzer J, Kenemans P, Mueck AO; FSDeducation Group. Bitzer J, et al. Maturitas. 2008 Mar 20;59(3):209-18. doi: 10.1016/j.maturitas.2008.01.005. Epub 2008 Mar 14. Maturitas. 2008. PMID: 18343056 Review.

9

Progestogens and target tissues: vascular systems.

Mueck AO, Seeger H. Mueck AO, et al. Maturitas. 2009 Apr 20;62(4):356-61. doi: 10.1016/j.maturitas.2008.12.003. Epub 2009 Jan 20. Maturitas. 2009. PMID: 19157733 Review.

10

Use of dydrogesterone in hormone replacement therapy.

Mueck AO, Seeger H, Bühling KJ. Mueck AO, et al. Maturitas. 2009 Dec;65 Suppl 1:S51-60. doi: 10.1016/j.maturitas.2009.09.013. Maturitas. 2009. PMID: 19836909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters